Absuridity Of the BIRB 796

This weakens the value of the intervention for the reduction of addictive medicine, and leaves Selleck Crizotinib what is probably the most important and weakest group of addicted patients with a potentially lethal medication use. ACKNOWLEDGEMENTS Thanks are extended to Dr. Hans Holmsgaard, Thybor?n, for his cooperation as well as for his willingness to contribute material. Footnotes CONFLICT OF INTEREST VKJ receives support from the Ministry of Health and Prevention pool for studies and initiatives related to drug issues, including compliance. Contributor Information Viggo K. J?rgensen, Primary Care Unit, Region Midtjylland. Holstebro (Denmark) Birgit S. Toft, Primary Care Unit, Region Midtjylland. Holstebro (Denmark)There is a need for tools to measure the information patients need in order for healthcare professionals in general, and particularly pharmacists, to communicate effectively and play an active part in the way patients manage their medicines. Previous research has developed and validated constructs to measure patients�� desires for information and their perceptions of how useful their medicines are. It is important to develop these tools for use in different settings and countries so that best practice is shared and is based on the best available evidence. Objectives this project sought to validate of a survey tool measuring the ��Extent of UGT1A7 Information Desired�� (EID), the ��Perceived Utility of Medicines�� (PUM), and the ��Anxiety about Illness�� (AI) that had been previously translated for use with Portuguese patients. Methods The scales were validated in a patient sample of 596: construct validity Selleck R428 was explored in Factor analysis (PCA) and internal consistency analysed using Cronbach��s alpha. Criterion validity was explored correlating scores to the AI scale and patients�� perceived health status. Discriminatory power was assessed using ANOVA. Temporal stability was explored in a sub-sample of patients who responded at two time points, using a T-test to compare their mean scores. Results Construct validity results indicated the need to remove 1 item from the Perceived Harm of Medicines (PHM) and Perceived Benefit of Medicines (PBM) for use in a Portuguese sample and the abandon of the tolerance scale. The internal consistency was high for the EID, PBM and AI scales (alpha>0.600) and acceptable for the PHM scale (alpha=0.536). All scales, except the EID, were consistent over time (p>0.05; p